Shanghai Junshi Biosciences Co Ltd (688180) — Cash Flow-to-Debt Ratio
Shanghai Junshi Biosciences Co Ltd (688180) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of CN¥-142.12 Million could theoretically repay 0% of its total liabilities (CN¥6.16 Billion) in one year. See 688180 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Junshi Biosciences Co Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Shanghai Junshi Biosciences Co Ltd across 12 annual periods. For the full cash flow conversion analysis, see Shanghai Junshi Biosciences Co Ltd (688180) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Shanghai Junshi Biosciences Co Ltd (2014–2025)
Year-by-year debt coverage analysis for Shanghai Junshi Biosciences Co Ltd. Check how high is Shanghai Junshi Biosciences Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | CN¥-478.14 Million | CN¥6.16 Billion | ▲ +73.9% |
| 2024 | -0.30x | CN¥-1.44 Billion | CN¥4.85 Billion | ▲ +40.3% |
| 2023 | -0.50x | CN¥-2.00 Billion | CN¥4.02 Billion | ▲ +21.9% |
| 2022 | -0.64x | CN¥-1.78 Billion | CN¥2.78 Billion | ▼ -170.3% |
| 2021 | -0.24x | CN¥-641.90 Million | CN¥2.72 Billion | ▲ +65.8% |
| 2020 | -0.69x | CN¥-1.50 Billion | CN¥2.17 Billion | ▲ +16.5% |
| 2019 | -0.83x | CN¥-1.19 Billion | CN¥1.43 Billion | ▼ -51.7% |
| 2018 | -0.55x | CN¥-510.76 Million | CN¥936.18 Million | ▲ +84.2% |
| 2017 | -3.46x | CN¥-347.08 Million | CN¥100.38 Million | ▲ +58.2% |
| 2016 | -8.26x | CN¥-185.21 Million | CN¥22.41 Million | ▼ -42.7% |
| 2015 | -5.79x | CN¥-82.03 Million | CN¥14.16 Million | ▼ -93.2% |
| 2014 | -3.00x | CN¥-39.19 Million | CN¥13.07 Million | — |